SCHEMBL2698475

SCHEMBL2698475

CC(C)(C)C(O)(CCCCc1ccccc1)Cn1nc[nH]c1=S

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
FDPS P14324 6/20 0.34
GGPS1 O95749 1/20 0.34
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
GAA P10253 1/20 0.32
G6PD P11413 1/20 0.32
GRM2 Q14416 1/20 0.32
GRM3 Q14832 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2126101 0.88 ALDH1A1 (0.46) ALDH1A1CYP3A4HRH3FDPS
SCHEMBL2127270 0.85 ALDH1A1 (0.37) ALDH1A1CYP3A4HSP90AA1HSP90AB1
SCHEMBL2127630 0.83 ALDH1A1 (0.36) ALDH1A1CYP3A4TDP1GAA
SCHEMBL1284598 0.82 ALDH1A1 (0.44) ALDH1A1CYP3A4
SCHEMBL2429204 0.82 ALDH1A1 (0.55) ALDH1A1CYP3A4FDPS
SCHEMBL1282504 0.77 L3MBTL1 (0.37) ALDH1A1CYP3A4HRH3TDP1MEN1
SCHEMBL1282484 0.77 L3MBTL1 (0.39) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL1282373 0.75 FDPS (0.37) ALDH1A1CYP3A4HRH3FDPS
SCHEMBL2125479 0.74 ACLY (0.37) ALDH1A1CYP3A4TDP1MEN1KMT2A
SCHEMBL1282179 0.74 FDPS (0.36) ALDH1A1HRH3FDPSLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108422-A1 Antifungal 1,2,4-triazolyl Derivatives BASF SE (DE) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108422-A1 Antifungal 1,2,4-triazolyl Derivatives ERG28, CYP51A1, DPM1 ALDH1A1 1943/4885CYP3A4 19/4885HRH3 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.